Semaglutide — Powder

Semaglutide Lyophilized Powder – Vial – Research Use Only

Semaglutide is a synthetic long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. It is supplied as a lyophilized powder in a sealed research vial and is extensively studied for its potent effects on metabolic signaling, glucose regulation, and appetite control.

In laboratory settings, researchers examine how Semaglutide mimics the action of native GLP-1 by binding to GLP-1 receptors, resulting in enhanced insulin secretion, suppressed glucagon release, slowed gastric emptying, and central regulation of appetite.

Researchers commonly study Semaglutide to explore its potential involvement in:

• Glucose-dependent insulin secretion and glycemic control pathways
• Suppression of glucagon release and hepatic glucose production
• Appetite suppression and central regulation of food intake
• Gastric emptying modulation and satiety signaling
• Weight management and adipose tissue metabolism
• Cardiovascular and metabolic health markers
• Long-acting GLP-1 receptor activation and its systemic effects

As a highly potent and long-acting GLP-1 receptor agonist, Semaglutide serves as a powerful research tool for investigating advanced approaches to type 2 diabetes, obesity, and metabolic disorders in controlled laboratory environments.

📄 Read the Full Research Overview →

For laboratory research use only. Not for human or veterinary, diagnostic, or therapeutic use.

Technical Specifications

• Chemical Name: Semaglutide
• CAS Number: 910463-68-2
• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
• Molecular Weight: 4113.64 g/mol
• Form: Lyophilized powder
• Appearance: White to off-white powder
• Purity: ≥98% (HPLC) – COA available upon request

Storage: Store at -20°C or lower, protected from light and moisture. Reconstitute using standard laboratory peptide protocols.

Category: Lyophilized Vial

Research Use Only. Not for human consumption. For laboratory, in vitro, or scientific research by qualified professionals only.